Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas.

导出 OA

翻译打印收藏纠错

第一作者： Giuseppe,Roberto

第一单位： Epidemiology Unit, Agenzia regionale di sanità della Toscana, Florence, Italy. giuseppe.roberto@ars.toscana.it.

作者： Giuseppe,Roberto ^[1] ; Francesco,Barone-Adesi ^[2] ; Francesco,Giorgianni ^[3] ; Valeria,Pizzimenti ^[3] ; Carmen,Ferrajolo ^[4] ; Michele,Tari ^[5] ; Claudia,Bartolini ^[6] ; Roberto,Da Cas ^[7] ; Marina,Maggini ^[8] ; Stefania,Spila-Alegiani ^[8] ; Paolo,Francesconi ^[8] ; Gianluca,Trifirò ^[7] ; Elisabetta,Poluzzi ^[3] ; Fabio,Baccetti ^[4] ; Rosa,Gini ^[9]

作者单位： Epidemiology Unit, Agenzia regionale di sanità della Toscana, Florence, Italy. giuseppe.roberto@ars.toscana.it. ^[1] Department of Pharmaceutical Sciences, University of Eastern Piedmont, Novara, Italy. ^[2] Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy. ^[3] Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands. ^[4] Department of Experimental medicine, Regional Center of Pharmacovigilance and Pharmacoepidemiology of Campania, University of Campania, Naples, Italy. ^[5] Local Health Unit of Caserta, Caserta, Italy. ^[6] Epidemiology Unit, Agenzia regionale di sanità della Toscana, Florence, Italy. ^[7] National Centre for Drug Research and Evaluation, National Institute of Health, Rome, Italy. ^[8] Department of Medical and Surgical Science, University of Bologna, Unit of Pharmacology, Bologna, Italy. ^[9] Unit of DiabetologyLocal, Health Authority of North-West Tuscany, Massa, Italy. ^[10]

关键词 Database network Dipeptidyl peptidase-4 inhibitors Drug utilization Glucagon-like peptide-1 analogues